← Open Payments lookup

JENNIFER NEUMAYER: Open Payments

NPI 1639432131 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$778 in 40 payments from 11 companies in 2025. Trend: 2023 $301 · 2024 $779 · 2025 $778

Food & beverage: $778
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$271
Novartis Pharmaceuticals Corporation12$167
Regeneron Healthcare Solutions, Inc.6$115
GlaxoSmithKline, LLC.3$55
ARS Pharmaceuticals Operations, Inc.2$44
Verona Pharma, Inc.1$28
CSL Behring1$24
Organon LLC1$22
Lilly USA, LLC1$20
Amgen Inc.1$17

Products named: FASENRA, DUPIXENT, AIRSUPRA, Rhapsido, NEFFY, TRELEGY ELLIPTA, TEZSPIRE, Ohtuvayre.

Industry payments across ID — which companies pay providers there.